Jesper Grarup

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)

Amanda Mocroft, Jens Lundgren, Miriam Lewis Sabin et al. · PLoS Medicine · 2013 · 360 citations · Full text

Public Health, Health Sciences, Clinical Epidemiology +10

Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial*

Jens‐Ulrik Stæhr Jensen, Lars Hein, Bettina Lundgren et al. · Critical Care Medicine · 2011 · 358 citations

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +17

All-cause mortality in treated HIV-infected adults with CD4 >=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration 

Charlotte Lewden, Vincent Bouteloup, Stéphane De Wit et al. · International Journal of Epidemiology · 2011 · 247 citations · Full text

Public Health, Health Sciences, Pharmacotherapy +16

Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

François Raffi, Abdel G. Babiker, Laura Richert et al. · The Lancet · 2014 · 176 citations

Pharmacy, Infectious Diseases, Pharmacology +13

Long-term Mortality in HIV-Positive Individuals Virally Suppressed for >3 Years With Incomplete CD4 Recovery

Frederik Neess Engsig, Robert Zangerle, François Dabis et al. · Clinical Infectious Diseases · 2014 · 172 citations · Full text

Public Health, Biostatistics, Infectious Diseases +14